Nova Biomedical’s Educational Webinar Series Presents:


ĞƚĞĐƟŽŶ ĂŶĚ DĂŶĂŐĞŵĞŶƚ ŽĨ ĐƵƚĞ <ŝĚŶĞLJ /ŶũƵƌLJ ŝŶ ƚŚĞ / h


Acute kidney injury (AKI) is a common complication in critically ill patients and is associated with high morbidity and mortality. AKI is often multifactorial, asymptomatic and difficult to predict. This webinar provides a review of the etiologies of AKI and a systematic approach toward its diagnosis and management with emphasis on fluid volume assessment and the use of AKI biomarkers. A point- of-care (POC) biomarkers profile has provided an additional tool to detect patients at high risk of AKI and improve their outcomes. We will review protocols that integrate the use of POC biomarkers into a multidisciplinary clinical response to potentially reduce AKI development and severity, and the number of patients who need dialysis.


Primary Presenter


Rolando Claure-Del Granado, MD, FASN Director, AKI/CRRT Program, Hospital Obrero, Cochabamba, Bolivia Professor of Medicine, Universidad Mayor de San Simon, School of Medicine, Bolivia Member at Large, International Society of Nephrology Executive Committee


KƉƟŽŶƐ ĨŽƌ /ĚĞŶƟĨLJŝŶŐ ĂŶĚ DĂŶĂŐŝŶŐ </ ŝŶ ƚŚĞ ,ŽƐƉŝƚĂů


AKI is an ongoing and escalating problem among ICU patients. Other areas of the hospital can also have patients who are at risk for AKI. Whether in the ICU or other hospital wards, AKI represents a complex disorder that requires frequent monitoring and early detection to achieve optimal outcomes. There are many testing modalities available to aid the clinician in AKI clinical decision making and management. These involve following trends in blood creatinine, plasma volume status, and electrolytes including ionized magnesium. This portion of the webinar will focus on point-of-care testing options available to clinicians that care for these patients.


Presenter Dennis Begos, MD, FACS, FACRS Medical Director, Medical and Scientific Affairs, Nova Biomedical


Webinar Dates:


Thursday, February 17th, 2:00 PM ET Thursday, March 3rd, 2:00 PM ET


Register Now at:


novabiomedical.com/aki-icu-mlo ĚƵĐĂƟŽŶĂů ƌĞĚŝƚƐ


This program offers 1 hour of P.A.C.E. continuing education credits. Nova Biomedical is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.®


Program.


This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23976. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned.


novabiomedical.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50